Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.". Dr. Casella is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Ambroise Wonkam is a Pediatrics specialist and a Medical Genetics provider in Baltimore, Maryland. Dr. Wonkam is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Anemia, Fragile X Syndrome, Pyle Disease, and Micrognathia.

Alexis Thompson is a Pediatrics specialist and an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Thompson is rated as an Elite provider by MediFind in the treatment of Anemia. Her top areas of expertise are Anemia, Infantile Neutropenia, Exocrine Pancreatic Insufficiency, Immune Thrombocytopenic Purpura (ITP), and Splenectomy.

Dr. Lydia H. Pecker is a pediatric hematologist and Director of the Young Adult Clinic at the Sickle Cell Center for Adults at Johns Hopkins. Dr. Pecker received her undergraduate degree in Africana studies from Brown University and earned her M.D. at the University of Pennsylvania School of Medicine. She completed residency training at Children’s Hospital at Montefiore and completed a fellowship at Children’s National Medical Center and the National Institutes of Health’s National Heart, Lung and Blood Institute before joining the Hopkins faculty in 2016. Dr. Pecker's NIH and foundation-funded research focuses on reproductive health in people with ovaries and sickle cell disease. Dr. Pecker is rated as an Elite provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Tubal Ligation.

Courtney Fitzhugh is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Fitzhugh is rated as an Elite provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Blood Clots, Atypical Hemolytic Uremic Syndrome (aHUS), Anemia, Splenectomy, and Bone Marrow Aspiration.

Dr. Ahmet Baschat is director of the Center for Fetal Therapy and professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. His areas of clinical expertise include prenatal diagnosis and therapy of a wide range of fetal conditions including congenital diaphragmatic hernia, intrauterine growth restriction, twin-to-twin transfusion syndrome (TTTS), as well as other complications of monochorionic twin pregnancies. Dr. Baschat received his undergraduate and medical degrees from The Royal College of Surgeons in Ireland. He earned his doctorate in medicine (Dr. Med) from the University of Lübeck, where he also completed a residency in obstetrics and gynecology. Dr. Baschat also completed residencies at Newton-Wellesley Hospital and at University of Maryland Medical Center. He performed a fellowship in maternal-fetal medicine at University of Maryland Medical Center and went on to develop its Center for Advanced Fetal Care. Dr. Baschat joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Baschat was professor and director of Maternal-Fetal Medicine and the Section of Fetal Therapy at the University of Maryland School of Medicine. Dr. Baschat’s research interests include interventions and management techniques for fetal growth restriction and placental insufficiency. He has also done extensive research on the use of high resolution prenatal ultrasound techniques, including Doppler and fetal echocardiography, to predict and detect fetal complications. Dr. Baschat serves on a variety of boards and is a member of the American Congress of Obstetricians and Gynecologists (ACOG), the International Society of Ultrasound in Obstetrics & Gynecology and the International Fetal Medicine and Surgery Society. He has been recognized with several awards and honors, including the 2010 Award for Excellence in Research by the Society for Maternal-Fetal Medicine. Dr. Baschat’s passion for developing an individualized care plan for each of his patients has been the hallmark of his practice. Dr. Baschat is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Twin-To-Twin Transfusion Syndrome, Intrauterine Growth Restriction, Bilateral Renal Agenesis Dominant Type, Diaphragmatic Hernia, and Endoscopy.

Michael Auerbach is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Auerbach is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Iron Deficiency Anemia, Anemia, Hypophosphatemia, and Childhood Iron Deficiency Anemia. Dr. Auerbach is currently accepting new patients.

Dr. Meredith Atkinson is an associate professor of pediatrics in the Johns Hopkins University School of Medicine. She provides care for children with kidney problems of any type, including patients on dialysis; patients with proteinuria, hematuria and chronic kidney disease; and kidney transplant. Dr. Atkinson's clinical research interests focus on chronic kidney disease and end-stage kidney disease in children. Her specific interests include mechanisms and treatment of anemia in chronic kidney disease and racial disparities in patient outcomes. She is the recipient of numerous research grants and awards, including a K23 Patient Oriented Research award from the National Institute of Diabetes and Digestive and Kidney Diseases/NIH, and young investigator grants from the National Kidney Foundation, the National Kidney Foundation of Maryland, the Thrasher Research Fund and Amgen Inc. She is currently the PI of the Renal Anhydramnios Fetal Therapy (RAFT) trial. She received her undergraduate degree in biology from Mount Holyoke College. She earned her M.D. from the University of Rochester School of Medicine and Dentistry. She completed a residency in pediatrics at Johns Hopkins, followed by a fellowship in pediatric nephrology at Hopkins, completed in June 2007. During her fellowship training, Dr. Atkinson received a master’s degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Atkinson joined the Johns Hopkins faculty in 2007. Dr. Atkinson was elected to the Society for Pediatric Research in 2014. She is a member of several professional organizations including the American Society of Nephrology, and is the president of the American Society of Pediatric Nephrology for 2024-2026. Dr. Atkinson is rated as an Advanced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Potter Syndrome, Lupus Nephritis, Glomerulonephritis, Anemia, and Kidney Transplant.

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Anemia. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

Dr. Cooke is Director of the Johns Hopkins Kimmel Cancer Center’s Pediatric Bone Marrow Transplantation Program. Prior to his appointment at Johns Hopkins, Dr. Cooke headed the Pediatric Blood and Marrow Transplantation Program at Rainbow Babies and Children’s Hospital, and University Hospitals Case Medical Center, in Cleveland, Ohio. He also co-directed the Hematologic Disorders Program of the Case Comprehensive Cancer Center at Case Western Reserve University. A nationally recognized transplantation immunology expert, Dr. Cooke focuses primarily on new strategies to prevent and treat graft-vs-host disease and lung complications following blood and bone marrow transplantation. His research efforts have been recognized by the Leukemia and Lymphoma Society and the American Society of Clinical Investigation. In addition to his younger patients, Dr. Cooke also cares for adolescents and young adults. Dr. Cooke is rated as an Advanced provider by MediFind in the treatment of Anemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Anemia, Aplastic Anemia, and Bone Marrow Transplant.

Dr. Jena Miller is an assistant professor in the Department of Gynecology and Obstetrics and the Department of Surgery at Johns Hopkins. She is also a member of the Johns Hopkins Center for Fetal Therapy. She has a wide range of training in fetal medicine and fetal therapy. Her expertise includes operative fetoscopy, management of complicated monochorionic twins, high-risk pregnancies, multiple gestations, prenatal diagnosis and treatment. Dr. Miller completed her undergraduate training at the University of North Florida, followed by medical school and residency at the University of Miami Miller School of Medicine. She completed a maternal-fetal medicine fellowship at the University of Maryland and pursued additional opportunities in fetal medicine in Europe. Prior to joining Johns Hopkins, Dr. Miller was an Assistant Professor in Maternal-Fetal Medicine at Eastern Virginia Medical School and served as the director for the Sentara EVMS Fetal Care Center. Dr. Miller’s research interests include risk assessment and management of complicated monochorionic pregnancies as well as use of simulation and modeling for improving fetal intervention techniques. She has received grant support from the Fetal Health Foundation for use of 3D printing of fetal spina bifida from ultrasound imaging. Dr. Miller is a fellow of the American Congress of Obstetricians and Gynecologists. She is dedicated to teaching and was awarded the APGO Excellence in Teaching Award in 2014. She is absolutely dedicated to finding the optimal management plan specifically for each family. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Twin-To-Twin Transfusion Syndrome, Myelomeningocele, Bilateral Renal Agenesis Dominant Type, Lung Agenesis, and Endoscopy.

Dr. Lance received her undergraduate degree from Princeton University and received her medical degree from the Medical University of South Carolina. She did residency in general pediatrics at Childrens Hospital Los Angeles and additional specialized residency training in neurodevelopmental disabilities at the Kennedy Krieger Institute. She received additional research training at Kennedy Krieger Institute/Johns Hopkins University School of Medicine and has a Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Selected Publications Gipson TT*, Lance EI*, (*co-first authors), Albury RA, Gentner MB, Leppert ML. Disparities in Identification of Comorbid Diagnoses in Children with ADHD. Clin Pediatr 2015 54(4):376-81. Lance EI*, Sreenivasan AK*, (*co-first authors), Zabel TA, Kossof EH, Comi AM. Aspirin Use in Sturge-Weber Syndrome: Side Effects and Clinical Outcomes. J Child Neurol 2013 28(2): 213-218. Lance EI, Casella JF, Everett AD, Barron-Casella E. Proteomic and Biomarker Studies and Neurological Complications of Pediatric Sickle Cell Disease. Proteomics Clin Appl 2014 8(11-12):813-27. Lance EI, Comi AM, Johnston MV, Casella JF, Shapiro, BK. Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease. Clin Pediatr ahead of print 2015 Jul 6. Lance EI, Dupont BR, Holden KR. Expansion of the Deletion 13q Syndrome Phenotype: A Case Report. J Child Neurol 2007 22(9): 1124-1127. Lance EI, Lanier K, Zabel TA, Comi AM. Stimulant Use in Patients with Sturge-Weber Syndrome: Safety and Efficacy. Ped Neurol 2014 51(5): 675-680. Lance EI, Shapiro BK. Confounding Diagnoses in the Neurodevelopmental Disabilities Population: A child with Hearing Loss, Absence Epilepsy, and Attention Deficit Hyperactivity Disorder. J Child Neurol 2013 28(5): 645 – 647. Lance EI, York, JM, Lee LC, Zimmerman, AW. Association between Regression and Self Injury among Children with Autism. Res Dev Disabil 2014 35(2): 408 – 413. Dr. Lance is rated as an Advanced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Anemia, Autism Spectrum Disorder, Distal 18q Deletion Syndrome, and 15q11.2 Microdeletion.

Dr. Moonjung Jung is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Jung graduated Summa Cum Laude from Ewha Womans University College of Medicine in Seoul, South Korea. She then completed the Internal Medicine residency training at Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX and the Hematology and Medical Oncology fellowship training at National Institutes of Health, Bethesda, MD. In 2016, Dr. Jung joined the Rockefeller University as an Instructor in Clinical investigation. She received M.S. in Clinical Investigation from the Rockefeller University. In 2021, Dr. Jung joined the Johns Hopkins University School of Medicine as faculty in the Division of Hematology. Dr. Jung is rated as an Advanced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Fanconi Anemia, Congenital Aplastic Anemia, Aplastic Anemia, and Anemia.

Dr. Gloria F. Gerber is an Assistant Professor of Medicine at Johns Hopkins University in the Division of Hematology. She received her undergraduate degree in Biology with High. Dr. Gerber is rated as an Advanced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Hemolysis, and Hemolytic Anemia.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of Anemia. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura.

Dr. Resar's studies molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Her research focuses on the HMG-I/Y gene family, which is widely overexpressed and functions as oncogenes in human cancers. Her laboratory recently developed transgenic mice overexpressing HMG-I; all mice develop aggressive lymphoid malignancy similar to leukemia and lymphoma in humans. Her studies also demonstrate that this gene is overexpressed in human lymphoid and other malignancies. Translational studies are underway to determine if overexpression of HMG-I is a marker for more aggressive human cancers. Resar's long-term goal is to develop more rational therapies that interfere with HMG-I/Y function in neoplastic transformation. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Anemia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).